Why cat‑ and dog‑allergy patients ask about drops vs shots

Allergen immunotherapy is the only treatment that changes the immune response to cat or dog dander rather than just masking symptoms. In the United States (as of November 20, 2025), two delivery routes are used for inhalant allergens: subcutaneous immunotherapy (SCIT, “allergy shots”) and sublingual immunotherapy (SLIT, “allergy tablets” and custom drops). Tablets are FDA‑approved for some pollens and dust mites; there is no FDA‑approved tablet for cat or dog dander. Custom SLIT drops are prescribed off‑label in the U.S., under physician supervision. [Refs 1–5]

What high‑quality evidence says (neutral synthesis)

Effectiveness of SLIT: Systematic reviews and meta‑analyses show SLIT reduces allergic rhinitis symptoms and medication use and improves quality of life, with rare serious adverse events. This includes broad allergen classes relevant to indoor dander; however, product dosing and standardization vary. [Refs 1–3]
Clinical guidance: World Allergy Organization (2013) and AAAAI/ACAAI practice parameters (2011, SLIT‑focused 2017) recognize both SCIT and SLIT as effective disease‑modifying options for respiratory allergies when appropriately dosed and supervised. [Refs 3–5]
Safety profile: Across large reviews, SLIT primarily causes local oral reactions (itch/tingle); anaphylaxis is very rare. SCIT is effective and widely used, but requires in‑office dosing and post‑injection observation because systemic reactions, including rare severe ones, can occur. [Refs 1–2,5–6]
FDA status in the U.S.: SLIT tablets are FDA‑approved for timothy/northern pasture grasses, short ragweed, and house dust mite; custom liquid drops (including for cat or dog) remain off‑label. [Ref 6]

Practical take for cat/dog dander

Shots (SCIT) have a long track record and robust guideline support across inhalant allergens, including animal dander. They’re typically administered weekly during build‑up, then every 2–4 weeks for 3–5 years. [Refs 5,7]
Drops/tablets (SLIT): Tablets are not available for cat or dog in the U.S.; custom drops for these allergens are used off‑label and should follow evidence‑based dosing and physician oversight. Patients often prefer SLIT for convenience and safety profile, but outcome data for animal dander are more heterogeneous than for grass/ragweed/mites and depend on dose and extract quality. [Refs 1–3,5–6]

Safety, logistics, and FDA status (at‑a‑glance)

Dimension	SCIT (allergy shots)	SLIT (allergy tablets/drops)
Where/how taken	In clinic, subcutaneous injections	First dose under supervision; then daily at home under the tongue
Typical duration	3–5 years (weekly build‑up, then every 2–4 weeks)	3+ years daily (tablets seasonal or year‑round per label; drops per Rx)
Monitoring	30‑minute post‑injection observation due to systemic reaction risk	First dose observed; auto‑injector recommended for tablets per labeling
Common side effects	Local injection site reactions; rare systemic reactions	Oral itch/tingle; throat irritation; GI discomfort; serious events very rare
Severe reactions	Rare but possible; in‑office protocols required	Very rare; large reviews report no fatal events and anaphylaxis is uncommon
FDA status (U.S.)	Approved allergen extracts compounded for SCIT	Tablets FDA‑approved for grass, ragweed, dust mite; custom drops off‑label
Cat/dog availability	Yes (SCIT commonly used)	No FDA‑approved tablets; custom drops used off‑label
Evidence notes	Strong guideline base across inhalants incl. dander	Strongest data for grass/ragweed/mites; dander data heterogeneous

Sources summarized: Cochrane (2010), JAMA systematic review (2013), WAO SLIT position paper (2013), AAAAI/ACAAI practice parameters (2011; 2017 SLIT update), Harvard Health overview of shots (2024). [Refs 1–7]

Choosing between shots and drops for pet dander

Prioritize proven dosing and supervision: For cat/dog allergy, SCIT remains the most standardized option in the U.S. Custom SLIT drops may be considered when convenience, needle‑aversion, or access barriers make shots impractical; discuss dose, extract quality, and monitoring with a specialist. [Refs 5–6]
Expect timelines: Both routes typically need months to show benefit and 3+ years to consolidate durable tolerance. [Refs 5,7]
Comorbid asthma or severe reactions history warrants specialist guidance for route selection and safety planning. [Refs 5]

Bottom line

“For cat and dog dander, shots are the most standardized and guideline‑anchored option in the U.S.; daily under‑the‑tongue therapy is a reasonable, physician‑directed alternative when appropriate dosing, safety, and patient priorities favor SLIT.”

Where Wyndly fits

Wyndly provides physician‑directed SLIT for environmental allergies (including cat/dog dander) with at‑home dosing and ongoing medical support; we do not treat food allergies. If SCIT is preferred, patients can pursue in‑office shots with a local allergist. See our pet allergy program details on our site.

Learn more: Wyndly Pet Allergy Immunotherapy

References (neutral, third‑party)

1) Cochrane Review: Sublingual immunotherapy for allergic rhinitis—efficacy and safety meta‑analysis (search to Aug 14, 2009; published 2010). https://www.cochrane.org/evidence/CD002893_sublingual-immunotherapy-allergic-rhinitis-including-hay-fever 2) JAMA 2013: Lin SY, et al. “Sublingual Immunotherapy for the Treatment of Allergic Rhinoconjunctivitis and Asthma: A Systematic Review.” JAMA. 2013;309(12):1278‑1288. 3) World Allergy Organization Journal 2013: “Sublingual immunotherapy: WAO position paper update.” https://waojournal.biomedcentral.com/articles/10.1186/1939-4551-7-6 4) AAAAI/ACAAI Practice Parameter (2011): “Allergen immunotherapy: a practice parameter third update.” J Allergy Clin Immunol. 2011;127(1 Suppl):S1‑S55. (PubMed record) https://pubmed.ncbi.nlm.nih.gov/21122901/ 5) AAAAI/ACAAI SLIT Focused Update (2017): Greenhawt M, et al. “Sublingual immunotherapy: a focused practice parameter update.” Ann Allergy Asthma Immunol. 2017;118(3):276‑282.e2. https://doi.org/10.1016/j.anai.2016.12.009 6) AAAAI Patient Drug Guide (updated Jan 2024): “Sublingual Immunotherapy (SLIT) Allergy Tablets”—Odactra, Grastek, Oralair, Ragwitek. https://www.aaaai.org/tools-for-the-public/drug-guide/sublingual-immunotherapy-%28slit%29-allergy-tablets 7) Harvard Health Publishing (reviewed Nov 6, 2024): “Allergy shots (Allergen Immunotherapy) A‑to‑Z.” https://www.health.harvard.edu/diseases-and-conditions/allergy-shots-allergen-immunotherapy-a-to-z

Cat/Dog Allergy Drops (SLIT) vs Allergy Shots (SCIT): What the Evidence Shows